Encompass Health CORP Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NYSE
Vanguard Portfolio Management has reported a 4.97% stake in Encompass Health Corp., holding 4,935,748 shares as of June 30, 2026.
NYSE
Vanguard Capital Management has filed a Schedule 13G reporting a 5.26% beneficial ownership stake in Encompass Health Corp.
NYSE
Vanguard Portfolio Management has reported beneficial ownership of 5% of Encompass Health Corp's common stock as of March 31, 2026.
NYSE
The Vanguard Group has amended its Schedule 13G for Encompass Health Corp, reporting 0% beneficial ownership following an internal realignment.
NYSE
Invesco Ltd. has reported a reduction in its beneficial ownership of Encompass Health Corp. common stock to 4.9%, falling below the 5% threshold.
NYSE
Wellington Management Group LLP and its affiliates have filed an amended Schedule 13G, reporting a 4.0% beneficial ownership stake in Encompass Health Corporation as of December 31, 2024.